These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 26035332
1. Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent. Qin L, Mei L, Shan Z, Huang Y, Pan X, Li G, Gu Y, Wu C. Drug Dev Ind Pharm; 2016; 42(2):307-16. PubMed ID: 26035332 [Abstract] [Full Text] [Related]
5. Preparation and evaluation of phytantriol liquid crystal as a liquid embolic agent. Fang X, Shen A. Pharm Dev Technol; 2020 Jun; 25(5):610-616. PubMed ID: 32008407 [Abstract] [Full Text] [Related]
9. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889 [Abstract] [Full Text] [Related]
10. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance. Liu M, Chen D, Wang C, Chen X, Wen Z, Cao Y, He H. J Drug Target; 2015 Nov; 23(9):800-5. PubMed ID: 25766079 [Abstract] [Full Text] [Related]
11. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules. Bisset NB, Boyd BJ, Dong YD. Int J Pharm; 2015 Nov 10; 495(1):241-248. PubMed ID: 26319637 [Abstract] [Full Text] [Related]
13. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Dong YD, Larson I, Hanley T, Boyd BJ. Langmuir; 2006 Nov 07; 22(23):9512-8. PubMed ID: 17073473 [Abstract] [Full Text] [Related]
14. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs. Pham AC, Hong L, Montagnat O, Nowell CJ, Nguyen TH, Boyd BJ. Mol Pharm; 2016 Jan 04; 13(1):280-6. PubMed ID: 26567591 [Abstract] [Full Text] [Related]
15. Phytantriol based smart nano-carriers for drug delivery applications. Akbar S, Anwar A, Ayish A, Elliott JM, Squires AM. Eur J Pharm Sci; 2017 Apr 01; 101():31-42. PubMed ID: 28137471 [Abstract] [Full Text] [Related]
17. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application. Wei W, Shi SJ, Liu J, Sun X, Ren K, Zhao D, Zhang XN, Zhang ZR, Gong T. J Drug Target; 2010 Aug 01; 18(7):557-66. PubMed ID: 20131981 [Abstract] [Full Text] [Related]
18. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Yang X, Liu Y, Zhao Y, Han M, Guo Y, Kuang H, Wang X. Int J Nanomedicine; 2016 Aug 01; 11():2979-94. PubMed ID: 27382284 [Abstract] [Full Text] [Related]
19. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Lee KW, Nguyen TH, Hanley T, Boyd BJ. Int J Pharm; 2009 Jan 05; 365(1-2):190-9. PubMed ID: 18790030 [Abstract] [Full Text] [Related]
20. Evaluating the link between self-assembled mesophase structure and drug release. Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Int J Pharm; 2011 Dec 12; 421(1):176-82. PubMed ID: 21963475 [Abstract] [Full Text] [Related] Page: [Next] [New Search]